Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
De-implementation of expensive blood saving measures in hip and knee arthroplasties: study protocol for the LISBOA-II cluster randomized trial.
Voorn VM, Marang-van de Mheen PJ, So-Osman C, Kaptein AA, van der Hout A, van den Akker-van Marle ME, Koopman-van Gemert AW, Dahan A, Nelissen RG, Vliet Vlieland TP, van Bodegom-Vos L. Voorn VM, et al. Among authors: van bodegom vos l, van den akker van marle me, van der hout a. Implement Sci. 2014 Apr 23;9:48. doi: 10.1186/1748-5908-9-48. Implement Sci. 2014. PMID: 24755214 Free PMC article. Clinical Trial.
Erythropoietin to reduce allogeneic red blood cell transfusion in patients undergoing total hip or knee arthroplasty.
Voorn VM, van der Hout A, So-Osman C, Vliet Vlieland TP, Nelissen RG, van den Akker-van Marle ME, Dahan A, Marang-van de Mheen PJ, van Bodegom-Vos L. Voorn VM, et al. Among authors: van bodegom vos l, van den akker van marle me, van der hout a. Vox Sang. 2016 Oct;111(3):219-225. doi: 10.1111/vox.12412. Epub 2016 Jun 17. Vox Sang. 2016. PMID: 27314459 Review.
The effectiveness of a de-implementation strategy to reduce low-value blood management techniques in primary hip and knee arthroplasty: a pragmatic cluster-randomized controlled trial.
Voorn VMA, Marang-van de Mheen PJ, van der Hout A, Hofstede SN, So-Osman C, van den Akker-van Marle ME, Kaptein AA, Stijnen T, Koopman-van Gemert AWMM, Dahan A, Vliet Vlieland TPMM, Nelissen RGHH, van Bodegom-Vos L. Voorn VMA, et al. Among authors: van bodegom vos l, van den akker van marle me, van der hout a. Implement Sci. 2017 May 30;12(1):72. doi: 10.1186/s13012-017-0601-0. Implement Sci. 2017. PMID: 28558843 Free PMC article. Clinical Trial.
Hospital variation in allogeneic transfusion and extended length of stay in primary elective hip and knee arthroplasty: a cross-sectional study.
Voorn VMA, Marang-van de Mheen PJ, van der Hout A, So-Osman C, van den Akker-van Marle ME, Koopman-van Gemert AWMM, Dahan A, Vliet Vlieland TPM, Nelissen RGHH, van Bodegom-Vos L; LISBOA study group. Voorn VMA, et al. Among authors: van bodegom vos l, van den akker van marle me, van der hout a. BMJ Open. 2017 Jul 20;7(7):e014143. doi: 10.1136/bmjopen-2016-014143. BMJ Open. 2017. PMID: 28729306 Free PMC article.
Efficacy, cost-utility and reach of an eHealth self-management application 'Oncokompas' that helps cancer survivors to obtain optimal supportive care: study protocol for a randomised controlled trial.
van der Hout A, van Uden-Kraan CF, Witte BI, Coupé VMH, Jansen F, Leemans CR, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM. van der Hout A, et al. Among authors: van uden kraan cf, van de poll franse lv. Trials. 2017 May 22;18(1):228. doi: 10.1186/s13063-017-1952-1. Trials. 2017. PMID: 28532439 Free PMC article. Clinical Trial.
Cost-utility of an eHealth application 'Oncokompas' that supports cancer survivors in self-management: results of a randomised controlled trial.
van der Hout A, Jansen F, van Uden-Kraan CF, Coupé VM, Holtmaat K, Nieuwenhuijzen GA, Hardillo JA, de Jong RJB, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee RJE, Bosscha K, van den Brekel MWM, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek WT, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM. van der Hout A, et al. Among authors: van uden kraan cf, van den broek wt, van den brekel mwm, van de poll franse lv. J Cancer Surviv. 2021 Feb;15(1):77-86. doi: 10.1007/s11764-020-00912-9. Epub 2020 Jul 12. J Cancer Surviv. 2021. PMID: 32656739 Free PMC article. Clinical Trial.
Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial.
van der Hout A, van Uden-Kraan CF, Holtmaat K, Jansen F, Lissenberg-Witte BI, Nieuwenhuijzen GAP, Hardillo JA, Baatenburg de Jong RJ, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee RJE, Bosscha K, van den Brekel MWM, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek WT, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM. van der Hout A, et al. Internet Interv. 2021 Jul 15;25:100429. doi: 10.1016/j.invent.2021.100429. eCollection 2021 Sep. Internet Interv. 2021. PMID: 34401388 Free PMC article.
The eHealth self-management application 'Oncokompas' that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most?
van der Hout A, Holtmaat K, Jansen F, Lissenberg-Witte BI, van Uden-Kraan CF, Nieuwenhuijzen GAP, Hardillo JA, Baatenburg de Jong RJ, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee RJE, Bosscha K, van den Brekel MWM, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek WT, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM. van der Hout A, et al. Among authors: van uden kraan cf, van den broek wt, van den brekel mwm, van de poll franse lv. Acta Oncol. 2021 Apr;60(4):403-411. doi: 10.1080/0284186X.2020.1851764. Epub 2020 Dec 21. Acta Oncol. 2021. PMID: 33345659 Clinical Trial.
Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial.
van der Hout A, van Uden-Kraan CF, Holtmaat K, Jansen F, Lissenberg-Witte BI, Nieuwenhuijzen GAP, Hardillo JA, Baatenburg de Jong RJ, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee RE, Bosscha K, van den Brekel MWM, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek WT, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM. van der Hout A, et al. Among authors: van uden kraan cf, van den broek wt, van den brekel mwm, van de poll franse lv. Lancet Oncol. 2020 Jan;21(1):80-94. doi: 10.1016/S1470-2045(19)30675-8. Epub 2019 Dec 11. Lancet Oncol. 2020. PMID: 31838009 Clinical Trial.
135 results